Cargando…

Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study

OBJECTIVES: Malondialdehyde-modified low-density lipoprotein (MDA-LDL) level is a marker of oxidative stress and is linked to progression of arteriosclerosis; however, the clinical factors affecting the oxidised LDL level have not been elucidated. We investigate various factors to identify correlati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Kazuo, Tanaka, Toshikazu, Nagoshi, Tomohisa, Sekiyama, Hiroshi, Arase, Satoshi, Minai, Kosuke, Ogawa, Takayuki, Yoshimura, Michihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305066/
https://www.ncbi.nlm.nih.gov/pubmed/25609666
http://dx.doi.org/10.1136/bmjopen-2014-005455
_version_ 1782354178140536832
author Ogawa, Kazuo
Tanaka, Toshikazu
Nagoshi, Tomohisa
Sekiyama, Hiroshi
Arase, Satoshi
Minai, Kosuke
Ogawa, Takayuki
Yoshimura, Michihiro
author_facet Ogawa, Kazuo
Tanaka, Toshikazu
Nagoshi, Tomohisa
Sekiyama, Hiroshi
Arase, Satoshi
Minai, Kosuke
Ogawa, Takayuki
Yoshimura, Michihiro
author_sort Ogawa, Kazuo
collection PubMed
description OBJECTIVES: Malondialdehyde-modified low-density lipoprotein (MDA-LDL) level is a marker of oxidative stress and is linked to progression of arteriosclerosis; however, the clinical factors affecting the oxidised LDL level have not been elucidated. We investigate various factors to identify correlation with MDA-LDL level in high-risk patients requiring catheter intervention. SETTING: Secondary care (cardiology), single-centre study. PARTICIPANTS: 600 patients who were admitted to our hospital and underwent cardiac catheterisation. PRIMARY AND SECONDARY OUTCOME MEASURES: Blood samples were obtained to measure lipid profiles and MDA-LDL level. RESULTS: With regard to smoking status, MDA-LDL level was significantly higher in ex-smokers/current smokers compared with non-smokers. Of note, there was no improvement of MDA-LDL level even in patients who had quit smoking. Multiple regression analysis showed that MDA-LDL level was positively correlated with LDL-cholesterol (LDL-C) level, Brinkman index and male gender. The correlation between smoking status and either MDA-LDL or LDL-C level was investigated in two groups: namely, patients with and patients without statin treatment. In the non-statin group, MDA-LDL level and MDA-LDL/LDL-C ratio were significantly higher in ex-smokers/current smokers compared with non-smokers, while no significant correlation was observed between smoking status and LDL-C level. In contrast, in the statin group, there were no significant correlations between smoking status and any of the cholesterol parameters. CONCLUSIONS: We found that MDA-LDL level was affected by multiple factors, such as smoking status, LDL-C level and male gender. The present findings give additional evidence that smoking should be prohibited from a MDA-LDL standpoint. Furthermore, statin therapy might have a beneficial effect on the reduction of MDA-LDL level.
format Online
Article
Text
id pubmed-4305066
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43050662015-01-28 Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study Ogawa, Kazuo Tanaka, Toshikazu Nagoshi, Tomohisa Sekiyama, Hiroshi Arase, Satoshi Minai, Kosuke Ogawa, Takayuki Yoshimura, Michihiro BMJ Open Cardiovascular Medicine OBJECTIVES: Malondialdehyde-modified low-density lipoprotein (MDA-LDL) level is a marker of oxidative stress and is linked to progression of arteriosclerosis; however, the clinical factors affecting the oxidised LDL level have not been elucidated. We investigate various factors to identify correlation with MDA-LDL level in high-risk patients requiring catheter intervention. SETTING: Secondary care (cardiology), single-centre study. PARTICIPANTS: 600 patients who were admitted to our hospital and underwent cardiac catheterisation. PRIMARY AND SECONDARY OUTCOME MEASURES: Blood samples were obtained to measure lipid profiles and MDA-LDL level. RESULTS: With regard to smoking status, MDA-LDL level was significantly higher in ex-smokers/current smokers compared with non-smokers. Of note, there was no improvement of MDA-LDL level even in patients who had quit smoking. Multiple regression analysis showed that MDA-LDL level was positively correlated with LDL-cholesterol (LDL-C) level, Brinkman index and male gender. The correlation between smoking status and either MDA-LDL or LDL-C level was investigated in two groups: namely, patients with and patients without statin treatment. In the non-statin group, MDA-LDL level and MDA-LDL/LDL-C ratio were significantly higher in ex-smokers/current smokers compared with non-smokers, while no significant correlation was observed between smoking status and LDL-C level. In contrast, in the statin group, there were no significant correlations between smoking status and any of the cholesterol parameters. CONCLUSIONS: We found that MDA-LDL level was affected by multiple factors, such as smoking status, LDL-C level and male gender. The present findings give additional evidence that smoking should be prohibited from a MDA-LDL standpoint. Furthermore, statin therapy might have a beneficial effect on the reduction of MDA-LDL level. BMJ Publishing Group 2015-01-21 /pmc/articles/PMC4305066/ /pubmed/25609666 http://dx.doi.org/10.1136/bmjopen-2014-005455 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Cardiovascular Medicine
Ogawa, Kazuo
Tanaka, Toshikazu
Nagoshi, Tomohisa
Sekiyama, Hiroshi
Arase, Satoshi
Minai, Kosuke
Ogawa, Takayuki
Yoshimura, Michihiro
Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study
title Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study
title_full Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study
title_fullStr Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study
title_full_unstemmed Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study
title_short Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study
title_sort increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305066/
https://www.ncbi.nlm.nih.gov/pubmed/25609666
http://dx.doi.org/10.1136/bmjopen-2014-005455
work_keys_str_mv AT ogawakazuo increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy
AT tanakatoshikazu increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy
AT nagoshitomohisa increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy
AT sekiyamahiroshi increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy
AT arasesatoshi increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy
AT minaikosuke increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy
AT ogawatakayuki increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy
AT yoshimuramichihiro increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy